Effects of mutagen-sensitive mus mutations on spontaneous mitotic recombination in Aspergillus

P Zhao1, E Kafer

  • 1Department of Biology, McGill University, Montreal, Canada.

Genetics
|April 1, 1992
PubMed

Insights

New DNA repair genes (musK-musS) in Aspergillus affect DNA repair and recombination. Some mutations decrease recombination, while others increase it, impacting gene conversion and crossing over differently.

Area of Science:

  • Genetics
  • Molecular Biology
  • DNA Repair

Background:

  • Radiation-induced mutants in Aspergillus nidulans are crucial for understanding DNA repair pathways.
  • Methyl methanesulfonate (MMS)-sensitive mutants define genes involved in DNA damage response.

Purpose of the Study:

  • To investigate the role of newly identified DNA repair genes (musK-musS) in mitotic recombination.
  • To determine how mutations in these genes affect intergenic crossing over and intragenic recombination.

Main Methods:

  • Assaying intergenic crossing over between color markers and centromeres in Aspergillus mutants.
  • Analyzing intragenic recombination between distinguishable adE alleles.
  • Genotyping intragenic recombinants to differentiate conversion types.

Main Results:

  • Four of eight mus mutations significantly altered recombination frequencies.
  • musK and musL mutations reduced recombination, while musN and musQ increased it.
  • musL deficiency led to chromosome loss instead of recombination, and differential effects on allele conversion were observed. musN and musQ showed distinct impacts on crossing over and gene conversion.

Conclusions:

  • The musL gene product is essential for recombination, and its deficiency results in chromosome loss upon DNA damage.
  • Mitotic gene conversion and crossing over are differentially regulated and can be independently affected by specific DNA repair gene mutations.
  • These findings highlight the complex interplay between DNA repair and recombination pathways in Aspergillus.

Related Concept Videos

Mismatch Repair01:36

Mismatch Repair

Overview
Mutations01:39

Mutations

Overview
In-vitro Mutagenesis01:16

In-vitro Mutagenesis

To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).